An Alzheimer's prevention study tests whether a treatment can delay or prevent cognitive decline in people who do not yet have dementia. Participants are usually identified by risk factors or biomarker status rather than by symptoms. CNS is a research partner of the GAP Foundation.
An Alzheimer's prevention study tests whether a treatment can delay or prevent cognitive decline in people who do not yet have dementia. Participants are usually identified by risk factors or biomarker status rather than by symptoms. CNS is a research partner of the GAP Foundation.
A treatment study enrols people who already have symptoms and asks whether they improve. A prevention study enrols people who do not, and asks whether the outcome can be avoided or delayed. That makes them longer, larger and dependent on carefully defined entry criteria, often involving biomarker status or family history rather than complaints.
Screening to confirm eligibility, which may include cognitive testing, blood work and sometimes imaging. Then scheduled visits over an extended period with repeated assessments. Some studies involve a placebo group, meaning you may not receive the active treatment. All of this is explained in the consent process before you commit.
Participation is voluntary and entirely separate from your clinical care; declining changes nothing about the treatment you receive. Reasonable questions include the time commitment, what happens if you withdraw, whether results are shared with you, and what the placebo chance is. CNS performs no infusions on site, so studies requiring them are conducted elsewhere. One practical point often missed: prevention studies frequently need a study partner, someone who knows you well and can attend some visits and answer questions about changes they have noticed. Ask early whether that is required, because finding somebody willing to commit for the duration is harder than it sounds and is a common reason people withdraw part-way through.
Clinical Neurology Specialists has been physician-owned since 1998, when Leo Germin, M.D., FAANEM founded it. Five board-certified neurologists and four advanced practice providers see patients at the Las Vegas and Henderson offices, each with its own AANEM-accredited electrodiagnostic laboratory.
Clinical Neurology Specialists is an adult outpatient neurology practice for patients 18 and older. The practice performs no surgery and operates no imaging suite, infusion suite or interventional pain programme, and provides no emergency or inpatient care.
Physician-reviewed. Reviewed by the physicians of Clinical Neurology Specialists — board-certified neurologists, AANEM-accredited electrodiagnostic laboratories, physician-owned since 1998. Reviewed 1 August 2026. This article is general education for adults 18 and older and is not a substitute for a consultation.
Sources and further reading: Alzheimers.gov: clinical trials; National Institute on Aging; MedlinePlus: Alzheimer disease.
Adults 18 and older, at the Las Vegas and Henderson offices. Call 702-804-1212 or request an appointment online.